Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
Laboratory of Cellular Biophysics, The Rockefeller University, New York, New York 10065, United States.
ACS Chem Biol. 2024 Sep 20;19(9):1888-1895. doi: 10.1021/acschembio.4c00237. Epub 2024 Aug 13.
Proteolysis-targeting chimeras (PROTACs) are bifunctional molecules that bind and recruit an E3 ubiquitin ligase to a targeted protein of interest, often through the utilization of a small molecule inhibitor. To expand the possible range of kinase targets that can be degraded by PROTACs, we sought to develop a PROTAC utilizing a hydrocarbon-stapled peptide as the targeting agent to bind the surface of a target protein of interest. In this study, we describe the development of a proteolysis-targeting chimera, dubbed apled nhibitor eptide - PRO or StIP-TAC, linking a hydrocarbon-stapled peptide with an E3 ligase ligand for targeted degradation of Protein Kinase A (PKA). This StIP-TAC molecule stimulated E3-mediated protein degradation of PKA, and this effect could be reversed by the addition of the proteasomal inhibitor MG-132. Further, StIP-TAC treatment led to a significant reduction in PKA substrate phosphorylation. Since many protein targets of interest lack structural features that make them amenable to small molecule targeting, development of StIP-TACs may broaden the potential range of protein targets using a PROTAC-mediated proteasomal degradation approach.
蛋白水解靶向嵌合体(PROTACs)是一种双功能分子,它通过利用小分子抑制剂将 E3 泛素连接酶募集到靶蛋白上,从而结合和招募靶蛋白。为了扩大 PROTACs 可降解的激酶靶标的范围,我们试图开发一种利用碳氢化合物订书肽作为靶向剂的 PROTAC,以结合靶蛋白表面。在这项研究中,我们描述了一种蛋白水解靶向嵌合体的开发,称为 apled nhibitor eptide-PRO 或 StIP-TAC,它将碳氢化合物订书肽与 E3 连接酶配体连接起来,用于靶向降解蛋白激酶 A(PKA)。这种 StIP-TAC 分子刺激了 E3 介导的 PKA 蛋白降解,并且这种效应可以通过添加蛋白酶体抑制剂 MG-132 来逆转。此外,StIP-TAC 处理导致 PKA 底物磷酸化显著减少。由于许多感兴趣的蛋白质靶标缺乏使其易于小分子靶向的结构特征,因此 StIP-TAC 的开发可能会扩大使用 PROTAC 介导的蛋白酶体降解方法的蛋白质靶标的潜在范围。